Search Results - "Olsson, F"

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States by Muffly, Lori, Pasquini, Marcelo C., Martens, Michael, Brazauskas, Ruta, Zhu, Xiaochun, Adekola, Kehinde, Aljurf, Mahmoud, Ballen, Karen K., Bajel, Ashish, Baron, Frederic, Battiwalla, Minoo, Beitinjaneh, Amer, Cahn, Jean-Yves, Carabasi, Mathew, Chen, Yi-Bin, Chhabra, Saurabh, Ciurea, Stefan, Copelan, Edward, D'Souza, Anita, Edwards, John, Foran, James, Freytes, Cesar O., Fung, Henry C., Gale, Robert Peter, Giralt, Sergio, Hashmi, Shahrukh K., Hildebrandt, Gerhard C., Ho, Vincent, Jakubowski, Ann, Lazarus, Hillard, Luskin, Marlise R., Martino, Rodrigo, Maziarz, Richard, McCarthy, Philip, Nishihori, Taiga, Olin, Rebecca, Olsson, Richard F., Pawarode, Attaphol, Peres, Edward, Rezvani, Andrew R., Rizzieri, David, Savani, Bipin N., Schouten, Harry C., Sabloff, Mitchell, Seftel, Matthew, Seo, Sachiko, Sorror, Mohamed L., Szer, Jeff, Wirk, Baldeep M., Wood, William A., Artz, Andrew

“…In this study, we evaluated trends and outcomes of allogeneic hematopoietic cell transplantation (HCT) in adults ≥70 years with hematologic malignancies across…”
Get full text

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy by Epperla, Narendranath, Li, Ang, Logan, Brent, Fretham, Caitrin, Chhabra, Saurabh, Aljurf, Mahmoud, Chee, Lynette, Copelan, Edward, Freytes, César O., Hematti, Peiman, Lazarus, Hillard M., Litzow, Mark, Nishihori, Taiga, Olsson, Richard F., Prestidge, Tim, Saber, Wael, Wirk, Baldeep, Yared, Jean A., Loren, Alison, Pasquini, Marcelo, Abraham, Allistair A., Agrawal, Vaibhav, Aljurf, Mahmoud, Askar, Medhat, Barba, Pere, Bertaina, Alice, Cahn, Jean‐Yves, Cerny, Jan, Choe, Hannah K., Diaz, Miguel Angel, Dvorak, Christopher, Farhadfar, Nosha, Gadalla, Shahinaz M., Gergis, Usama, Ganguly, Siddhartha, Hashmi, Shahrukh, Kasow, Kimberly A., Nathan, Sunita, Nusrat, Roomi, Seo, Sachiko, Shah, Niketa C.

“…Summary Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of allogeneic transplantation (allo‐HCT). The incidence and risk factors…”
Get full text

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study by D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A, Kyle, Robert A, Kumar, Shaji, Comenzo, Raymond L, Peter Gale, Robert, Lazarus, Hillard M, Savani, Bipin N, Cornell, Robert F, Weiss, Brendan M, Vogl, Dan T, Freytes, César O, Scott, Emma C, Landau, Heather J, Moreb, Jan S, Costa, Luciano J, Ramanathan, Muthalagu, Callander, Natalie S, Kamble, Rammurti T, Olsson, Richard F, Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L, Wood, William A, Mark, Tomer M, Hari, Parameswaran

“…Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of…”
Get full text

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis by Bona, Kira, Brazauskas, Ruta, He, Naya, Lehmann, Leslie, Abdel-Azim, Hisham, Ahmed, Ibrahim A, Al-Homsi, A Samer, Aljurf, Mahmoud, Arnold, Staci D., Badawy, Sherif M, Battiwalla, Minoo, Beattie, Sara, Bhatt, Neel S., Dalal, Jignesh, Dandoy, Christopher E., Diaz, Miguel Angel, Frangoul, Haydar A., Freytes, César O., Ganguly, Siddhartha, George, Biju, Gomez-Almaguer, David, Hahn, Theresa, Kamble, Rammurti T., Knight, Jennifer M., LeMaistre, C. Fred, Law, Jason, Lazarus, Hillard M., Majhail, Navneet S., Olsson, Richard F., Preussler, Jaime, Savani, Bipin N., Schears, Raquel, Seo, Sachiko, Sharma, Akshay, Srivastava, Alok, Steinberg, Amir, Szwajcer, David, Wirk, Baldeep, Yoshimi, Ayami, Khera, Nandita, Wood, William A., Hashmi, Shahrukh, Duncan, Christine N., Saber, Wael

“…Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric…”
Get full text

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies by Olsson, R F, Logan, B R, Chaudhury, S, Zhu, X, Akpek, G, Bolwell, B J, Bredeson, C N, Dvorak, C C, Gupta, V, Ho, V T, Lazarus, H M, Marks, D I, Ringdén, O T H, Pasquini, M C, Schriber, J R, Cooke, K R

“…Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis ( n =23 272) which investigates means to…”
Get full text

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT by Mehta, Rohtesh S, Holtan, Shernan G, Wang, Tao, Hemmer, Michael T, Spellman, Stephen R, Arora, Mukta, Couriel, Daniel R, Alousi, Amin M, Pidala, Joseph, Abdel-Azim, Hisham, Agrawal, Vaibhav, Ahmed, Ibrahim, Al-Homsi, A Samer, Aljurf, Mahmoud, Antin, Joseph H, Askar, Medhat, Auletta, Jeffery J, Bhatt, Vijaya Raj, Chee, Lynette, Chhabra, Saurabh, Daly, Andrew, DeFilipp, Zachariah, Gajewski, James, Gale, Robert Peter, Gergis, Usama, Hematti, Peiman, Hildebrandt, Gerhard C, Hogan, William J, Inamoto, Yoshihiro, Martino, Rodrigo, Majhail, Navneet S, Marks, David I, Nishihori, Taiga, Olsson, Richard F, Pawarode, Attaphol, Diaz, Miguel Angel, Prestidge, Tim, Rangarajan, Hemalatha G, Ringden, Olle, Saad, Ayman, Savani, Bipin N, Schoemans, Hélène, Seo, Sachiko, Schultz, Kirk R, Solh, Melhem, Spitzer, Thomas, Storek, Jan, Teshima, Takanori, Verdonck, Leo F, Wirk, Baldeep, Yared, Jean A, Cahn, Jean-Yves, Weisdorf, Daniel J

“…There is no consensus on the best choice of an alternative donor (umbilical cord blood [UCB], haploidentical, one-antigen mismatched [7/8]-bone marrow [BM], or…”
Get full text

Fabrication of bulk τ MnAl–C magnets by hot-pressing from ε-phase gas-atomized and milled powder by Muñoz-Rodríguez, C., Feng, L., Palmero, E.M., Mix, T., Rial, J., Olsson, F., Skårman, B., Vidarsson, H., Larsson, P.-O., Woodcock, T.G., Bollero, A.

“…Isotropic nanocrystalline MnAlC particles with quasi-spherical shape were synthesized by gas-atomization being afterwards milled for a short time of 60 s…”
Get full text

Metapopulation effective size and conservation genetic goals for the Fennoscandian wolf (Canis lupus) population by Laikre, L, Olsson, F, Jansson, E, Hössjer, O, Ryman, N

“…The Scandinavian wolf population descends from only five individuals, is isolated, highly inbred and exhibits inbreeding depression. To meet international…”
Get full text

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases by Arnold, Staci D, Brazauskas, Ruta, He, Naya, Li, Yimei, Aplenc, Richard, Jin, Zhezhen, Hall, Matt, Atsuta, Yoshiko, Dalal, Jignesh, Hahn, Theresa, Khera, Nandita, Bonfim, Carmem, Majhail, Navneet S, Diaz, Miguel Angel, Freytes, Cesar O, Wood, William A, Savani, Bipin N, Kamble, Rammurti T, Parsons, Susan, Ahmed, Ibrahim, Sullivan, Keith, Beattie, Sara, Dandoy, Christopher, Munker, Reinhold, Marino, Susana, Bitan, Menachem, Abdel-Azim, Hisham, Aljurf, Mahmoud, Olsson, Richard F, Joshi, Sarita, Buchbinder, Dave, Eckrich, Michael J, Hashmi, Shahrukh, Lazarus, Hillard, Marks, David I, Steinberg, Amir, Saad, Ayman, Gergis, Usama, Krishnamurti, Lakshmanan, Abraham, Allistair, Rangarajan, Hemalatha G, Walters, Mark, Lipscomb, Joseph, Saber, Wael, Satwani, Prakash

“…Advances in allogeneic hematopoietic cell transplantation for sickle cell disease have improved outcomes, but there is limited analysis of healthcare…”
Get full text

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma by Munshi, Pashna N., Vesole, David, Jurczyszyn, Artur, Zaucha, Jan Maciej, St. Martin, Andrew, Davila, Omar, Agrawal, Vaibhav, Badawy, Sherif M., Battiwalla, Minoo, Chhabra, Saurabh, Copelan, Edward, Kharfan‐Dabaja, Mohamed A., Farhadfar, Nosha, Ganguly, Siddhartha, Hashmi, Shahrukh, Krem, Maxwell M., Lazarus, Hillard M., Malek, Ehsan, Meehan, Kenneth, Murthy, Hemant S., Nishihori, Taiga, Olin, Rebecca L., Olsson, Richard F., Schriber, Jeffrey, Seo, Sachiko, Shah, Gunjan, Solh, Melhem, Tay, Jason, Kumar, Shaji, Qazilbash, Muzaffar H., Shah, Nina, Hari, Parameswaran N., D’Souza, Anita

“…Background Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an important therapy in the management of patients with multiple myeloma…”
Get full text

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant by Dandoy, Christopher E, Kim, Soyoung, Chen, Min, Ahn, Kwang Woo, Ardura, Monica I, Brown, Valerie, Chhabra, Saurabh, Diaz, Miguel Angel, Dvorak, Christopher, Farhadfar, Nosha, Flagg, Aron, Ganguly, Siddartha, Hale, Gregory A, Hashmi, Shahrukh K, Hematti, Peiman, Martino, Rodrigo, Nishihori, Taiga, Nusrat, Roomi, Olsson, Richard F, Rotz, Seth J, Sung, Anthony D, Perales, Miguel-Angel, Lindemans, Caroline A, Komanduri, Krishna V, Riches, Marcie L

“…Patients undergoing hematopoietic stem cell transplant (HSCT) are at risk for bloodstream infection (BSI) secondary to translocation of bacteria through the…”
Get full text

Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report by Schriber, Jeffrey R., Hari, Parameswaran N., Ahn, Kwang Woo, Fei, Mingwei, Costa, Luciano J., Kharfan‐Dabaja, Mohamad A., Angel‐Diaz, Miguel, Gale, Robert P., Ganguly, Siddharatha, Girnius, Saulius K., Hashmi, Shahrukh, Pawarode, Attaphol, Vesole, David H., Wiernik, Peter H., Wirk, Baldeep M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Usmani, Saad Z., Mark, Tomer M., Nieto, Yago L., D'Souza, Anita

“…BACKGROUND Race/ethnicity remains an important barrier in clinical care. The authors investigated differences in the receipt of autologous hematopoietic cell…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience by Olsson, Richard F, Hagelberg, Stefan, Schiller, Bodil, Ringdén, Olle, Truedsson, Lennart, Åhlin, Anders

“…BACKGROUNDHuman C1q deficiency is associated with systemic lupus erythematosus (SLE) and increased susceptibility to severe bacterial infections. These…”
Get full text

Expression of the vascular endothelial growth factor system (VEGF) in the porcine oviduct during the estrous cycle by López Albors, O., Olsson, F., Llinares, A.B., Gutiérrez, H., Latorre, R., Candanosa, E., Guillén-Martínez, A., Izquierdo-Rico, M.J.

“…The expression and localization of VEGFA and its main receptors Flt-1 and KDR is characterized in the oviduct throughout the porcine estrous cycle. Oviducts…”
Get full text

Localization of the Cu(111) surface state by single Cu adatoms by OLSSON, F. E, PERSSON, M, BORISOV, A. G, GAUVACQ, J.-P, LAGOUTE, J, FÖLSCH, S

Get full text

Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma by Ahmed, Sairah, Ghosh, Nilanjan, Ahn, Kwang W., Khanal, Manoj, Litovich, Carlos, Mussetti, Alberto, Chhabra, Saurabh, Cairo, Mitchell, Mei, Matthew, William, Basem, Nathan, Sunita, Bejanyan, Nelli, Olsson, Richard F., Dahi, Parastoo B., Poel, Marjolein, Steinberg, Amir, Kanakry, Jennifer, Cerny, Jan, Farooq, Umar, Seo, Sachiko, Kharfan‐Dabaja, Mohamed A., Sureda, Anna, Fenske, Timothy S., Hamadani, Mehdi

“…Summary Reduced‐intensity conditioning (RIC) allogeneic haematopoietic cell transplantation (allo‐HCT) is a curative option for select relapsed/refractory…”
Get full text

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia by Lee, Catherine J., Kim, Soyoung, Tecca, Heather R., Bo-Subait, Stephanie, Phelan, Rachel, Brazauskas, Ruta, Buchbinder, David, Hamilton, Betty K., Battiwalla, Minoo, Majhail, Navneet S., Lazarus, Hillard M., Shaw, Peter J., Marks, David I., Litzow, Mark R., Chhabra, Saurabh, Inamoto, Yoshihiro, DeFilipp, Zachariah, Hildebrandt, Gerhard C., Olsson, Richard F., Kasow, Kimberly A., Liesveld, Jane L., Rotz, Seth J., Badawy, Sherif M., Bhatt, Neel S., Yared, Jean A., Page, Kristin M., Arellano, Martha L., Kent, Michael, Farhadfar, Nosha, Seo, Sachiko, Hematti, Peiman, Freytes, César O., Rovó, Alicia, Ganguly, Siddhartha, Nathan, Sunita, Burns, Linda, Shaw, Bronwen E., Muffly, Lori S.

“…There is marked paucity of data regarding late effects in adolescents and young adults (AYAs) who undergo myeloablative conditioning (MAC) allogeneic…”
Get full text

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma by Myers, Regina M., Hill, Brian T., Shaw, Bronwen E., Kim, Soyoung, Millard, Heather R., Battiwalla, Minoo, Majhail, Navneet S., Buchbinder, David, Lazarus, Hillard M., Savani, Bipin N., Flowers, Mary E. D., D'Souza, Anita, Ehrhardt, Matthew J., Langston, Amelia, Yared, Jean A., Hayashi, Robert J., Daly, Andrew, Olsson, Richard F., Inamoto, Yoshihiro, Malone, Adriana K., DeFilipp, Zachariah, Margossian, Steven P., Warwick, Anne B., Jaglowski, Samantha, Beitinjaneh, Amer, Fung, Henry, Kasow, Kimberly A., Marks, David I., Reynolds, Jana, Stockerl‐Goldstein, Keith, Wirk, Baldeep, Wood, William A., Hamadani, Mehdi, Satwani, Prakash

“…BACKGROUND Autologous hematopoietic cell transplantation (auto‐HCT) is a standard therapy for relapsed classic Hodgkin lymphoma (cHL) and diffuse large B‐cell…”
Get full text

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation by Jagadeesh, Deepa, Majhail, Navneet S., He, Yizeng, Ahn, Kwang W., Litovich, Carlos, Ahmed, Sairah, Aljurf, Mahmoud, Bacher, Ulrike, Badawy, Sherif M., Bejanyan, Nelli, Cairo, Mitchell, Cerny, Jan, Epperla, Narendranath, Farhadfar, Nosha, Freytes, César O., Gale, Robert Peter, Haverkos, Bradley, Hossain, Nasheed, Inwards, David, Kamble, Rammurti T., Kenkre, Vaishalee P., Lazarus, Hillard M., Lazaryan, Aleksandr, Lekakis, Lazaros, Mei, Matthew, Murthy, Hemant S., Mussetti, Alberto, Nathan, Sunita, Nishihori, Taiga, Olsson, Richard F., Ramakrishnan Geethakumari, Praveen, Savani, Bipin N., Yared, Jean A., Fenske, Timothy S., Kharfan‐Dabaja, Mohamed A., Sureda, Anna, Hamadani, Mehdi

“…Background Although rituximab‐based high‐dose therapy is frequently used in diffuse large B cell lymphoma (DLBCL) patients undergoing autologous hematopoietic…”
Get full text

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults by Metheny, Leland, Callander, Natalie S., Hall, Aric C., Zhang, Mei-Jei, Bo-Subait, Khalid, Wang, Hai-Lin, Agrawal, Vaibhav, Al-Homsi, A. Samer, Assal, Amer, Bacher, Ulrike, Beitinjaneh, Amer, Bejanyan, Nelli, Bhatt, Vijaya Raj, Bredeson, Chris, Byrne, Michael, Cairo, Mitchell, Cerny, Jan, DeFilipp, Zachariah, Perez, Miguel Angel Diaz, Freytes, César O., Ganguly, Siddhartha, Grunwald, Michael R., Hashmi, Shahrukh, Hildebrandt, Gerhard C., Inamoto, Yoshihiro, Kanakry, Christopher G., Kharfan-Dabaja, Mohamed A., Lazarus, Hillard M., Lee, Jong Wook, Nathan, Sunita, Nishihori, Taiga, Olsson, Richard F., Ringdén, Olov, Rizzieri, David, Savani, Bipin N., Savoie, Mary Lynn, Seo, Sachiko, van der Poel, Marjolein, Verdonck, Leo F., Wagner, John L., Yared, Jean A., Hourigan, Christopher S., Kebriaei, Partow, Litzow, Mark, Sandmaier, Brenda M., Saber, Wael, Weisdorf, Daniel, de Lima, Marcos

“…•The 5-year disease-free survival (DFS) for patients with therapy-related myelodysplastic syndrome and therapy-related acute myelogenous leukemia (t-AML) was…”
Get full text